Search

Quanglong N. Truong

Examiner (ID: 17769, Phone: (571)270-0719 , Office: P/1615 )

Most Active Art Unit
1615
Art Unit(s)
1615
Total Applications
746
Issued Applications
510
Pending Applications
123
Abandoned Applications
141

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 20583286 [patent_doc_number] => 20260068876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-03-12 [patent_title] => COMPOSITION [patent_app_type] => utility [patent_app_number] => 19/319209 [patent_app_country] => US [patent_app_date] => 2025-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4720 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19319209 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/319209
COMPOSITION Sep 3, 2025 Pending
Array ( [id] => 20817581 [patent_doc_number] => 12673035 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-07-07 [patent_title] => Solid dosage forms of elafibranor [patent_app_type] => utility [patent_app_number] => 19/302463 [patent_app_country] => US [patent_app_date] => 2025-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11862 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19302463 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/302463
Solid dosage forms of elafibranor Aug 17, 2025 Issued
Array ( [id] => 20098975 [patent_doc_number] => 20250228911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-17 [patent_title] => BURDOCK SEED OIL-CONTAINING COMPOSITION AND METHOD FOR PRODUCING SAME [patent_app_type] => utility [patent_app_number] => 19/169459 [patent_app_country] => US [patent_app_date] => 2025-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19169459 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/169459
Burdock seed oil-containing composition and method for producing same Apr 2, 2025 Issued
Array ( [id] => 20270677 [patent_doc_number] => 12440441 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-10-14 [patent_title] => Pharmaceutical solution of amlodipine [patent_app_type] => utility [patent_app_number] => 19/013003 [patent_app_country] => US [patent_app_date] => 2025-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8893 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19013003 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/013003
Pharmaceutical solution of amlodipine Jan 7, 2025 Issued
Array ( [id] => 20057123 [patent_doc_number] => 20250195345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-19 [patent_title] => WHIPPED FORMULATIONS [patent_app_type] => utility [patent_app_number] => 18/950919 [patent_app_country] => US [patent_app_date] => 2024-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16932 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18950919 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/950919
WHIPPED FORMULATIONS Nov 17, 2024 Pending
Array ( [id] => 19798959 [patent_doc_number] => 20250064884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-27 [patent_title] => KOMBUCHA NATURAL HEALTH PROUDCTS [patent_app_type] => utility [patent_app_number] => 18/949461 [patent_app_country] => US [patent_app_date] => 2024-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6481 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18949461 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/949461
KOMBUCHA NATURAL HEALTH PROUDCTS Nov 14, 2024 Pending
Array ( [id] => 19982664 [patent_doc_number] => 20250120886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-17 [patent_title] => WHIPPED FORMULATIONS [patent_app_type] => utility [patent_app_number] => 18/929954 [patent_app_country] => US [patent_app_date] => 2024-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13558 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18929954 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/929954
WHIPPED FORMULATIONS Oct 28, 2024 Pending
Array ( [id] => 19768280 [patent_doc_number] => 20250049706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-13 [patent_title] => MAGNETIC FERRITIC NANOCOMPOSITE [patent_app_type] => utility [patent_app_number] => 18/926415 [patent_app_country] => US [patent_app_date] => 2024-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10256 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18926415 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/926415
MAGNETIC FERRITIC NANOCOMPOSITE Oct 24, 2024 Pending
Array ( [id] => 19752915 [patent_doc_number] => 20250041480 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-06 [patent_title] => METHOD AND DEVICE FOR IN VIVO BRONCHUS REGENERATION [patent_app_type] => utility [patent_app_number] => 18/921769 [patent_app_country] => US [patent_app_date] => 2024-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9714 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18921769 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/921769
METHOD AND DEVICE FOR IN VIVO BRONCHUS REGENERATION Oct 20, 2024 Pending
Array ( [id] => 19752609 [patent_doc_number] => 20250041174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-06 [patent_title] => Skin Barrier Protective Delivery Systems and Methods Thereof [patent_app_type] => utility [patent_app_number] => 18/920446 [patent_app_country] => US [patent_app_date] => 2024-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6276 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18920446 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/920446
Skin Barrier Protective Delivery Systems and Methods Thereof Oct 17, 2024 Pending
Array ( [id] => 19752674 [patent_doc_number] => 20250041239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-06 [patent_title] => ORALLY DISSOLVING ANTIMICROBIAL FILM COMPOSITIONS & METHODS OF THEIR USE [patent_app_type] => utility [patent_app_number] => 18/919150 [patent_app_country] => US [patent_app_date] => 2024-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65895 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18919150 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/919150
ORALLY DISSOLVING ANTIMICROBIAL FILM COMPOSITIONS & METHODS OF THEIR USE Oct 16, 2024 Pending
Array ( [id] => 19875743 [patent_doc_number] => 20250108000 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-03 [patent_title] => IMPLANTABLE NANOCHANNEL DELIVERY DEVICES [patent_app_type] => utility [patent_app_number] => 18/915635 [patent_app_country] => US [patent_app_date] => 2024-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12323 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18915635 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/915635
IMPLANTABLE NANOCHANNEL DELIVERY DEVICES Oct 14, 2024 Pending
Array ( [id] => 20039384 [patent_doc_number] => 20250177606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-05 [patent_title] => FLOWABLE ACELLULAR TISSUE MATRIX PRODUCTS AND METHODS OF PRODUCTION [patent_app_type] => utility [patent_app_number] => 18/909404 [patent_app_country] => US [patent_app_date] => 2024-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4401 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18909404 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/909404
FLOWABLE ACELLULAR TISSUE MATRIX PRODUCTS AND METHODS OF PRODUCTION Oct 7, 2024 Pending
Array ( [id] => 19707688 [patent_doc_number] => 20250017830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-16 [patent_title] => SKIN BARRIER PROTECTIVE DELIVERY SYSTEMS AND METHODS THEREOF [patent_app_type] => utility [patent_app_number] => 18/900108 [patent_app_country] => US [patent_app_date] => 2024-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30501 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18900108 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/900108
SKIN BARRIER PROTECTIVE DELIVERY SYSTEMS AND METHODS THEREOF Sep 26, 2024 Pending
Array ( [id] => 20185902 [patent_doc_number] => 12397002 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-08-26 [patent_title] => PH stabilized ophthalmic dexamethasone compositions [patent_app_type] => utility [patent_app_number] => 18/893806 [patent_app_country] => US [patent_app_date] => 2024-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8079 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18893806 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/893806
PH stabilized ophthalmic dexamethasone compositions Sep 22, 2024 Issued
Array ( [id] => 20185901 [patent_doc_number] => 12397001 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-08-26 [patent_title] => Treatment of ocular inflammation with ophthalmic compositions [patent_app_type] => utility [patent_app_number] => 18/893798 [patent_app_country] => US [patent_app_date] => 2024-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7935 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18893798 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/893798
Treatment of ocular inflammation with ophthalmic compositions Sep 22, 2024 Issued
Array ( [id] => 19691217 [patent_doc_number] => 20250009762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-09 [patent_title] => PH STABILIZED OPHTHALMIC COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 18/893810 [patent_app_country] => US [patent_app_date] => 2024-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12731 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18893810 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/893810
PH stabilized ophthalmic compositions Sep 22, 2024 Issued
Array ( [id] => 19691215 [patent_doc_number] => 20250009760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-09 [patent_title] => TREATMENT OF DIABETIC RETINOPATHY WITH OPHTHALMIC COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 18/893805 [patent_app_country] => US [patent_app_date] => 2024-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12743 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18893805 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/893805
Treatment of diabetic retinopathy with ophthalmic compositions Sep 22, 2024 Issued
Array ( [id] => 19691212 [patent_doc_number] => 20250009757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-09 [patent_title] => TREATMENT OF OCULAR INFLAMMATION FOLLOWING OCULAR SURGERY [patent_app_type] => utility [patent_app_number] => 18/893790 [patent_app_country] => US [patent_app_date] => 2024-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12732 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18893790 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/893790
Treatment of ocular inflammation following ocular surgery Sep 22, 2024 Issued
Array ( [id] => 20185900 [patent_doc_number] => 12397000 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-08-26 [patent_title] => Stabilized ophthalmic dexamethasone compositions [patent_app_type] => utility [patent_app_number] => 18/893796 [patent_app_country] => US [patent_app_date] => 2024-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8811 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18893796 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/893796
Stabilized ophthalmic dexamethasone compositions Sep 22, 2024 Issued
Menu